Get the latest news updates on Quantzig’s developments — our service portfolio expansions, successful project completions and engagement insights, accolades, and more through our press releases and media mentions hub.
Why Choose Quantzig’s Pharmacovigilance Analytics Solutions? Through our comprehensive portfolio of pharmacovigilance solutions, we support the entire pharmacovigilance journey of our clients right from proof-of-concept to end-to-end service customization. From...
What is Pharmacovigilance? Pharmacovigilance also known as drug safety, refers to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problem. Here ‘adverse effects’ refer to any untoward medical occurrence...
Greater emphasis on drug safety is one of the key drivers of the growing demand for pharmacovigilance (PV) software. With the focus on all the major drug regulations being on improving the drug quality and prevention of drug-related problems, pharma companies are...
A physician’s journey begins with assimilating an enormous amount of data about a patient to determine the proper diagnosis and right treatment plan. A hospital’s financial performance is highly dependent upon quality and outcomes, rather than patient volumes alone....
Business Challenge Improving process safety during clinical trials for new cardiology drug A global conglomerate in the healthcare industry, with ongoing clinical trials in 15+ countries, wanted to ensure process safety and real-time monitoring of the trials. Request...
Our advanced analytics expertise spans across industries, sectors, and functions, which enables us to deliver robust, agile solutions to all our clients. These are our core competencies, formed through years of experience.
We create focused advanced analytics solutions, turning data into actionable, intelligent insights, to optimize and transform different areas of the client’s business.
Our free resources shed light on our extensive expertise and equip you with information to accelerate decision-making, growth, and innovation.